Patent ID: 11865217
Assignee: JOHN J. MASIZ
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 24:
25. A method for transdermal delivery of a formulation having an active ingredient to a mammal, said mammal having a body surface that comprises a stratum corneum, an epidermis, a basement membrane, and a dermis; the method comprises:
a) administering at least one penetration agent to the body surface, wherein the penetration agent comprises a solvent, a lipophilic agent, a hydrophilic agent, or a combination thereof;
b) administering at least one basement membrane disruptor to the body surface, wherein the basement membrane disruptor is present in an amount ranging from about 0.2% w/w and about 10% w/w;
c) administering at least one vaso-modulator; and
d) administering at least one active ingredient;
wherein the formulation allows for penetration of the active ingredient to the dermis.